Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2015-09-30
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi Focal Visual Outcome Study Using Different Near Additions
NCT00960700
Clinical Outcomes After Implantation of a Monofocal Hydrophobic IOL, Bi-Flex 877PAY With POB-MA Preloaded Injector
NCT06469541
Visual Acuity After the Combined Binocular Implantation of +2.0 Diopters and +3.0 Diopters Oculentis Multifocal Intraocular Lenses.
NCT02633228
Multifocal-toric IOL Compared to Multifocal IOL Combined With Limbal Relaxing Incisions for Correction of Moderate Astigmatism During Cataract Surgery
NCT06277349
A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular Lenses
NCT02264457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bi flex M multifocal intraocular lens
Subjects implanted bilaterally with the Bi flex M multifocal intraocular lens
Bi flex M multifocal intraocular lens
Multifocal intraocular lens
Bi flex 1.8 monofocal intraocular
Subjects implanted bilaterally with the Bi flex 1.8 monofocal intraocular lens
Bi flex 1.8 monofocal intraocular lens
Standard monofocal intraocular lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bi flex M multifocal intraocular lens
Multifocal intraocular lens
Bi flex 1.8 monofocal intraocular lens
Standard monofocal intraocular lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients requiring primary IOL implantation
* Patients with a potential corrected visual acuity of 20/40 or better on clinical assessment
* Patients with normal anterior segments apart from cataracts
* Subjects with clear intraocular media other than cataract
Exclusion Criteria
* Microphthalmia
* Corneal decompensation or Endothelial Insufficiency
* Pseudo exfoliation
* High myopia
* Pars planitis
* Patient with greater than 1 dioptre of preoperative corneal astigmatism
* Subjects who are expected to require retinal laser treatment
* Previous intraocular and/or corneal surgery
* History of uveitis, glaucoma, proliferative diabetic retinopathy, pseudoexfoliation, macular degeneration that may affect potential best corrected visual acuity of 20/40 or better
* Operative complications of posterior capsular rupture, zonular dehiscence, incomplete continuous curvilinear capsulorhexis, severe iris /corneal trauma and inability to achieve secure placement in the designated location
* Subjects using a systemic medication that is known to cause ocular side effects
* Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days
* Subjects who have only one eye with potentially good vision
* Patients who are not willing to cooperate for the follow up period
* Visual eccentricity of greater than 0.7mm
* Pregnant women
* Patients where it is not possible to take informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BMI Southend Hospital
OTHER
Dr Phillip J Buckhurst
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Phillip J Buckhurst
Associate Professor (Senior Lecturer)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip J Buckhurst, PhD
Role: PRINCIPAL_INVESTIGATOR
Plymouth University
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MC001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.